Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Robert F. Kennedy Jr.

πŸ‘€ Speaker
See mentions of this person in podcasts
6381 total appearances

Appearances Over Time

Podcast Appearances

The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Well, let me say this. Here is my bottom line. Show me or call all of these guys who you talk to on, you know, pull off it and the other people and ask them to show you a scientific study for each vaccine that shows that this vaccine is averting poor harm and it's causing. That's all I ask for that.

3683.813 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Well, let me say this. Here is my bottom line. Show me or call all of these guys who you talk to on, you know, pull off it and the other people and ask them to show you a scientific study for each vaccine that shows that this vaccine is averting poor harm and it's causing. That's all I ask for that.

3683.813 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Look at health outcomes. OK, let me can I give you an example?

3716.488 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Look at health outcomes. OK, let me can I give you an example?

3716.488 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Look at health outcomes. OK, let me can I give you an example?

3716.488 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would characterize Anthony Fauci as the preeminent architect of agency capture, of the transfer of NIAID and also its parent agency, NIH, from a public health agency to an agency that is primarily concerned with drug promotion, with drug development and drug promotion, and partnering with the pharmaceutical industry on profit-making enterprises.

3801.728 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would characterize Anthony Fauci as the preeminent architect of agency capture, of the transfer of NIAID and also its parent agency, NIH, from a public health agency to an agency that is primarily concerned with drug promotion, with drug development and drug promotion, and partnering with the pharmaceutical industry on profit-making enterprises.

3801.728 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would characterize Anthony Fauci as the preeminent architect of agency capture, of the transfer of NIAID and also its parent agency, NIH, from a public health agency to an agency that is primarily concerned with drug promotion, with drug development and drug promotion, and partnering with the pharmaceutical industry on profit-making enterprises.

3801.728 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would say that that is the least important factor in this problem.

3839.17 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would say that that is the least important factor in this problem.

3839.17 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

I would say that that is the least important factor in this problem.

3839.17 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Legally, he can make money and he does. We know at least one patent he has. Any product that is developed by NIAID, anybody who works on that product that he designates can get a patent margin rights on that product and entitle them under the federal rules now. to collect $150,000 a year for royalty for life.

3852.207 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Legally, he can make money and he does. We know at least one patent he has. Any product that is developed by NIAID, anybody who works on that product that he designates can get a patent margin rights on that product and entitle them under the federal rules now. to collect $150,000 a year for royalty for life.

3852.207 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

Legally, he can make money and he does. We know at least one patent he has. Any product that is developed by NIAID, anybody who works on that product that he designates can get a patent margin rights on that product and entitle them under the federal rules now. to collect $150,000 a year for royalty for life.

3852.207 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So he has four of his top employees who each have margin rights, patent rights, royalty rights for the Moderna vaccine. because we paid for it. We put a US taxpayer through Fauci, put in $1.5 billion, now 2.5 billion to develop that vaccine. NIH claims half of the vaccine, to own half of the vaccine.

3879.986 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So he has four of his top employees who each have margin rights, patent rights, royalty rights for the Moderna vaccine. because we paid for it. We put a US taxpayer through Fauci, put in $1.5 billion, now 2.5 billion to develop that vaccine. NIH claims half of the vaccine, to own half of the vaccine.

3879.986 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So he has four of his top employees who each have margin rights, patent rights, royalty rights for the Moderna vaccine. because we paid for it. We put a US taxpayer through Fauci, put in $1.5 billion, now 2.5 billion to develop that vaccine. NIH claims half of the vaccine, to own half of the vaccine.

3879.986 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So it stands to make billions and billions of dollars, the agency, but also high-level individuals, influential individuals in the agency, people who are very loyal to Tony Fauci. and get awarded through Fauci the rights to collect lifetime royalties on those products. And they make hundreds and hundreds of products. They develop hundreds and hundreds of products and all of those are potential,

3903.499 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So it stands to make billions and billions of dollars, the agency, but also high-level individuals, influential individuals in the agency, people who are very loyal to Tony Fauci. and get awarded through Fauci the rights to collect lifetime royalties on those products. And they make hundreds and hundreds of products. They develop hundreds and hundreds of products and all of those are potential,

3903.499 View full episode β†’
The Megyn Kelly Show
Incoming HHS Secretary Robert F. Kennedy Jr. Deep Dive, Part 1 - on Fauci, Vaccines, and Big Pharma

So it stands to make billions and billions of dollars, the agency, but also high-level individuals, influential individuals in the agency, people who are very loyal to Tony Fauci. and get awarded through Fauci the rights to collect lifetime royalties on those products. And they make hundreds and hundreds of products. They develop hundreds and hundreds of products and all of those are potential,

3903.499 View full episode β†’